<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01599572</url>
  </required_header>
  <id_info>
    <org_study_id>8541</org_study_id>
    <nct_id>NCT01599572</nct_id>
  </id_info>
  <brief_title>Effect of Zinc Supplementation on Serum Zinc Level in Nursing Home Elderly</brief_title>
  <official_title>Zinc Intervention in Nursing Home Elderly</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tufts University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Boston University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hebrew SeniorLife</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Boston Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Tufts University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: Zinc supplementation has the potential to improve serum zinc levels and immunity&#xD;
      of zinc deficient nursing home elderly.&#xD;
&#xD;
      Objective: To determine the effect of zinc supplementation of 30mg/d for 3 months on serum&#xD;
      zinc levels and T-cell mediated function of zinc deficient nursing home elderly.&#xD;
&#xD;
      Design: This is a randomized, double-blind, placebo-controlled study. Outcome measures&#xD;
      included change in serum zinc levels and various T-cell mediated immune factors between&#xD;
      baseline and month 3.&#xD;
&#xD;
      Hypotheses: The investigators hypothesize that zinc supplementation of 30mg/d for 3 months&#xD;
      will improve serum zinc levels as well as various T-cell mediated immune factors in zinc&#xD;
      deficient nursing home elderly.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Four hundred and forty-two medical charts were screened from three participating nursing&#xD;
      homes; 53 nursing home elderly were eligible and therefore were screened for low serum zinc&#xD;
      levels (&lt;70µg/dL). Of these, 31 (58%) had low serum zinc levels. Participants were randomized&#xD;
      into either the placebo (N=16) or the zinc supplemented (N=15) group. Six participants did&#xD;
      not complete the study for various reasons including refusal to take study capsules, and&#xD;
      advice from their physicians; one participant in the zinc group experienced nausea on two&#xD;
      consecutive days following ingestion of the zinc capsule at the beginning of the study. A&#xD;
      total of 25 participants completed the study with 13 and 12 receiving the placebo and zinc&#xD;
      capsules, respectively, over a period of three months&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2009</start_date>
  <completion_date type="Actual">January 2011</completion_date>
  <primary_completion_date type="Actual">January 2011</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>serum zinc concentration</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>lymphocyte proliferation</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">31</enrollment>
  <condition>Disorder of Immune Function</condition>
  <arm_group>
    <arm_group_label>30mg/day zinc supplementation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>30mg/day of zinc supplement provided for 3 months to zinc deficient elderly</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>zinc supplementation</intervention_name>
    <description>30mg/day of zinc in the form of zinc gluconate</description>
    <arm_group_label>30mg/day zinc supplementation</arm_group_label>
    <other_name>zinc was provided in the form of zinc gluconate</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Males and females ≥65 years of age.&#xD;
&#xD;
          2. More than 6 months life expectancy, in the judgment of their study physician.&#xD;
&#xD;
          3. Willing to be randomized to one of the treatment groups.&#xD;
&#xD;
          4. Able to swallow pills.&#xD;
&#xD;
          5. Not currently on antibiotics.&#xD;
&#xD;
          6. Subjects consuming DRI levels of supplements and willing to replace their supplement&#xD;
             with our control supplement.&#xD;
&#xD;
          7. Supplements of calcium, vitamin D, and iron will be permitted.&#xD;
&#xD;
          8. Willing to receive influenza vaccine.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Anticipated transfer or discharge within three months of enrollment.&#xD;
&#xD;
          2. Bed- or room-bound continuously for the last three months.&#xD;
&#xD;
          3. Presence of lung neoplastic diseases or other active neoplastic diseases requiring&#xD;
             chemotherapy and/or use of immunosuppressive drugs (including no more than 10 mg/day&#xD;
             of prednisone).&#xD;
&#xD;
          4. Naso-gastric or other tube feeding.&#xD;
&#xD;
          5. Long-term intravenous or urethral catheters (30 days).&#xD;
&#xD;
          6. Presence of tracheostomy or chronically ventilator-dependent.&#xD;
&#xD;
          7. Consuming supplements containing more than the DRI level of nutrients known to affect&#xD;
             the immune response, i.e. vitamins E, C, B6, selenium, zinc, or β -carotene and&#xD;
             unwilling to stop.&#xD;
&#xD;
          8. Chronic prophylactic antibiotic treatment (low percent of subjects meeting other&#xD;
             inclusion criteria). 9) Protein energy malnutrition defined as albumin &lt; 3.0 g/dl and&#xD;
             BMI &lt;18 kg/m2.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Simin N Meydani, DVM, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>HNRCA-tufts University</affiliation>
  </overall_official>
  <verification_date>May 2015</verification_date>
  <study_first_submitted>May 14, 2012</study_first_submitted>
  <study_first_submitted_qc>May 15, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 16, 2012</study_first_posted>
  <last_update_submitted>May 19, 2015</last_update_submitted>
  <last_update_submitted_qc>May 19, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 21, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>zinc supplementation</keyword>
  <keyword>serum zinc concentration</keyword>
  <keyword>lymphocyte proliferation</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Zinc</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

